Skip to content

Clinical study of Aamavata Gajasimha Modaka and Khandshunthi in the treatment of Aamavata.

An open randomized comparative clinical study of Aamavata Gajasimha Modaka (Rasendra Sara Sangraha) with Khandshunthi (Bhavprakash) in the management of Aamavata. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108181
Enrollment
132
Registered
2026-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

APMs SION AYURVED MAHAVIDYALAYA SION
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical signs and symptoms of Aamavata i.e. Angamardana (body ache),Aruchi (anorexia), Jvara (fever), Apaka (indigestion), Shotha (swelling), Sandhishool (pain), Sandhi graham (morning stiffness) 2.Aamavata with features of Rheumatoid Arthritis as specified in 2010 ACR-EULAR classification criteria for Rheumatoid Arthritis with less than 10 years of chronicity, Subjects aged between 20 to 60 years of either gender willing to participate in the study and ready to sign informed consent form 3.Patients on DMARDs will also be included

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mothers 2.Serious systemic disorders like uncontrolled DM,CA,RHD 3.The patients who had deformities will be excluded from the study for example, ulnar deviation, swan neck deformities, ankylosis of wrist and elbow 4.Patients with Aamavata upadrava

Design outcomes

Primary

MeasureTime frame
1. Gradation of following criteria on a scale 0 to 4,0 being no symptom 4 being maximum severity of the symptom 1. Angamardana (body ache) 2. Aruchi (anorexia) 3. Jvara (fever) 4. Apaka (indigestion) 5. Shotha (swelling) 6. Sandhishool (pain) 7. Sandhi graham (morning stiffness) 2. Weight will be measured Timepoint: AT baseline, 15th day, 30th day,45th day, 60th day

Secondary

MeasureTime frame
1.ESR 2.RAPID 3 3.CRP 4.VAS 5.ANTI-CCP 6.DAS28 7.WOMAC 8.ACR-EULAR 9.RA QUANTITATIVETimepoint: AT baseline, 60th day

Countries

India

Contacts

Public ContactDr Anaya Ashish Pathrikar

APMs Ayurved Mahavidyalaya Sion

anayapathrikar@gmail.con9870214595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026